“…In other words, while they may cause antimuscarinic effects (e.g., dry mouth, blurry vision, constipation, urinary retention, drowsiness), they should not theoretically produce antinicotinic effects (e.g., neuromuscular blockade or skeletal muscle weakness) the latter would be particularly problematic in myasthenia gravis (16). However, in one case it was reported that cetirizine appeared to trigger an episode of diplopia, dysphagia, and facial weakness in a patient with a history of myasthenia gravis previously in complete stable remission; the mechanism by which this likely occurred is unclear but may be related to the anticholinergic properties of the disease (17).…”